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Abstract
Purpose—There are no published data from specific regions of sub-Saharan Africa describing
the clinical and pathological characteristics and molecular subtypes of invasive breast cancer by
ethnic group. The purpose of this study was to investigate these characteristics among the three
major ethno-cultural groupings in Kenya.

Author Manuscript

Methods—The study included women with pathologically-confirmed breast cancer seen between
March 2012 and May 2015 at 11 hospitals throughout Kenya. Socio-demographic, clinical, and
reproductive data were collected by questionnaire, and pathology review and
immunohistochemistry were performed centrally.
Results—The 846 cases included 661 Bantus (78.1%), 143 Nilotes (16.9%), 19 Cushites (2.3%),
and 23 patients of mixed ethnicity (2.7%). In analyses comparing the two major ethnic groups,
Bantus were more educated, more overweight, had an older age at first birth and had a younger
age at menopause than Nilotes (p<0.05 for all comparisons). In analyses restricted to definitive
surgery specimens, there were no statistically significant differences in tumour characteristics or
molecular subtypes, although the Nilote tumours tended to be larger (OR for ≥ 5 cm vs. < 2 cm:
3.86, 95%CI: 0.77, 19.30) and were somewhat more likely to be HER2-enriched (OR for HER2enriched vs. Luminal A/B: 1.41, 95%CI: 0.79, 2.49).

Author Manuscript

Conclusion—This case series showed no significant differences in breast cancer tumour
characteristics or molecular subtypes, but significant differences in socio-demographic
characteristics and reproductive factors, among the three major ethnic groups in Kenya. We
suggest further evaluation of ethnic differences in breast cancer throughout the genetically and
culturally diverse populations of sub-Saharan Africa.
Keywords
Breast cancer; Kenya; Ethnic differences; Ethnicity; sub Saharan Africa
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BACKGROUND
Breast cancer (BC) is the most common female malignancy worldwide, accounting for 1.7
million new cases and 521,900 deaths in 2012.[1] According to the Nairobi Populationbased Cancer Registry, breast cancer is the most common malignancy in Kenyan women,
accounting for 23% of all incident cases.[2]
The effect of race and ethnicity on breast cancer (BC) stage of presentation, tumor biology
and treatment response has been the subject of much investigation and controversy, with
numerous studies reporting that the distribution of BC molecular subtypes differs among
various races and ethnic groups.

Author Manuscript

A qualitative systematic review of breast cancer demographics, size, stage, grade,
histological type, extra-mammary involvement, and hormone receptor status in patients from
Africa, the Middle East, Eastern Europe, Mexico, the Caribbean and South America reported
that women with BC in these regions present with large aggressive tumors, and that distant
metastases are frequently present at the time of diagnosis.[3] Compared with White
American women, Black African women have also been reported to be younger at diagnosis,
[4] to have a higher frequency of triple negative tumors,[5] and to be more likely to present
with Stage III/IV disease.[6] A review of the histopathological differences between BC in
African American (AA) and White Americans also reports that the former tend to have a
higher nuclear grade, a higher proportion of lymph node positive tumors, and a younger agespecific incidence of triple negative tumors as compared to White Americans.[7]

Author Manuscript

Furthermore, a recent registry data review from South Africa reported that similar to the
Western populations, the age distribution for breast cancer is bimodal in both Black and
White South African women, however Black South African women had a younger age
distribution of early onset breast cancer than all other groups studied.[8]
In Kenya, there are approximately 40–50 tribes which can be divided into 3 main ethnocultural groupings: the Bantus who originated from West Africa after 400 AD, the Nilotic
tribes who migrated from regions of the present day Sudan and Egypt around 400 AD, and
the Cushitic tribes who came from northern Africa around 2000 BC (Fig 1a).
The largest ethnic groups in Kenya, the Kikuyus, are of Bantu ancestry, while the Luos
residing in the western part of Kenya are of Nilotic descent. The populations that inhabit the
northern parts of Kenya belong to the Cushitic lineage.

Author Manuscript

The objective of this study was to investigate the differences in-patient, clinical and
pathological characteristics of breast cancer in the three major ethno-cultural groupings in
Kenya, given their distinct ancestral origin.

METHODS
Study design and setting
This was a Kenya-wide study involving a total of 11 health institutions (Supplementary
Table 1) that recruited patients with pathologically confirmed breast cancer between March
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2012 and May 2015. The study was coordinated by Aga Khan University Hospital, Nairobi,
which is a 300-bed private not-for-profit hospital that provides tertiary level health care
services in Kenya. The collaborating hospitals in this study are located in various parts of
Kenya and their patient catchment area reflects the distribution of the total population and
the three major ethnic groups (Fig. 1b).
Data collection
Relevant socio-demographic, reproductive, and clinical data were collected from all
consenting patients using structured questionnaires and clinical data abstraction case report
forms.

Author Manuscript

The ethnicity of patients was determined through self-reporting by respondents of their
parents’ and maternal and paternal grandparents’ tribal affiliations. The tribes were assigned
to the corresponding three major ethnic groups; Bantu, Nilotes and Cushites[9] If all
maternal and paternal grandparents and parents did not belong to the same tribe, that
patient’s ethnicity was categorized as mixed. Due to sparse numbers, patients reporting
“mixed” ethnicity (N=23, 2.7%) were excluded from the analytic population.

Author Manuscript

All breast cancer tissues blocks were submitted to Aga Khan University Hospital, Nairobi to
undergo central pathology review and immunohistochemistry. Tumor size, tumor grade,
presence of lympho-vascular invasion, lymph node metastases and extra nodal extension
were documented. ER/PR/HER2 status was analyzed on the Dako Automated platform as
previously reported,[10] and tumors were assigned into 3 major breast cancer molecular
subtypes based on immunohistochemistry: ER and/or PR positive and HER2 positive or
negative (Luminal A/B), ER/PR negative and HER2 positive (HER2 enriched), and ER/PR
and HER2 negative (Triple Negative).
Data entry and verification
All data were double entered. If data were missing, or needed clarification, an additional
secondary review of the patient files was carried out by the data collection team. Finally,
SQL scripts were prepared to facilitate data extraction.
Data Analysis
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Distributions of socio-demographic and reproductive risk factors, tumor pathology
characteristics, and tumor hormone receptor status were examined across the three ethnic
groups (Bantu, Nilotes, and Cushite) and evaluated by Chi-square and Fisher exact tests as
appropriate. Because of the small numbers of Cushite patients, these statistical tests were
also rerun after restricting the analysis to the two largest ethnic groups, Bantus and Nilotes.
Logistic regression models were used to estimate odds ratios (ORs) and 95% confidence
intervals (95% CIs) for associations between Bantu or Nilote ethnicity and the tumor
characteristics (tumor pathology characteristics and hormone receptor status). Risk factors
associated with both ethnicity and the tumor characteristics of interest were included in
multivariate logistic regression models, and the final models were determined using
backwards elimination. In exploratory analyses attempting to better understand observed
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risk factor associations with ethnic group, we also evaluated interrelationships between
select socio-demographic characteristics with tumor characteristics.
Analyses of socio-demographic, reproductive factors and hormone receptor status included
all participants with relevant data. In contrast, the tumor pathology characteristics (tumor
size, tumor grade, lympho-vascular invasion, lymph node metastasis, and extranodal
extension) were only analyzed in the 396 (48.1%) cases that underwent definitive surgery.
All analyses were performed using SAS 9.3 (SAS Institute, Inc., Cary, NC) and statistical
significance was defined as p<0.05.

RESULTS

Author Manuscript

A total of 823 female study patients with invasive breast tumors were included in the
analysis, 661 (80.3%) were Bantus, 143 (17.4%) were Nilotes, and 19 (2.3%) were Cushites.
Of these 823 study participants, 427 (51.9%) were diagnosed by core biopsy only, and 396
(48.1%) had both a core biopsy and definitive surgery (lumpectomy or mastectomy). 351
(53.1%) of the Bantus, 37 (25.9%) of the Nilotes, and 8 (42.1%) of the Cushites had
definitive surgery.
Sociodemographic and Behavioral Characteristics

Author Manuscript

Overall, the majority (53.9%) of women were younger than age 50 years at breast cancer
diagnosis, with a median (interquartile range) age of 48 (40-57) years (Table 1). Whereas
median age at diagnosis was similar for Bantus (48 years) and Nilotes (52 years), the median
age at diagnosis for Cushites was much younger (36 years) (p=0.03). About half (50.2%) of
the women received only primary school or no education. The most common occupations
were farmer (30.8%) and employed worker (23.3%), and only 18.5% said they worked as
housewives. By body mass index (BMI, kg/m2), nearly 70% of the women were overweight
(39.2%) or obese (29.5%). Nearly half (42.7%) of the women were exposed to smoking, but
very few of them (3.3%) reported ever having smoked or used smokeless tobacco
themselves, and only 8.5% used alcohol.
When the analytic population was limited to Bantus and Nilotes, Bantu patients were
slightly more educated (51.6% vs. 46.2% with secondary education or above) and slightly
more overweight or obese (70.1% vs. 63.2%), and they were more likely to work as farmers
(34.0% vs. 20.3%). Nilote patients, on the other hand, were more likely to work as employed
workers (31.5% vs. 21.9%) or housewives (26.6% vs. 15.6%).
Reproductive Health Factors

Author Manuscript

In terms of reproductive health factors in the overall study population, nearly all of the
participants reported having normal (age 12-14 years) or late (age ≥15 years) menarche
(49.9% and 49.0%, respectively) (Table 2). Most women (67.9%) had at least three children,
for most (62.2%) their age at first pregnancy was between the ages of 20 and 29 years, and
the vast majority (90.1%) reported at least 15 cumulative months of breastfeeding. A little
less than half (48.1%) of participants were postmenopausal at diagnosis, among whom most
(57.9%) reported an age at menopause <50 years. The majority (92.2%) of patients reported
no family history of breast cancer.
Breast Cancer Res Treat. Author manuscript; available in PMC 2018 February 01.
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Though based on small numbers, the Cushites seemed to present with a different
reproductive profile as compared with the Bantus and Nilotes: a greater proportion of
Cushites were <20 years at first pregnancy (52.6% vs. 24% (Bantus) and 35% (Nilotes);
p=0.0008) and were premenopausal at diagnosis (73.7% vs. 52.7% (Bantus) and 45.1%
(Nilotes); p=0.04). When reproductive health factors in Bantus and Nilotes were compared,
Bantus were more likely to report older age at first pregnancy (72.3% vs. 58.8% ≥20 years)
and younger age at menopause (62.2 vs. 43.9% <50 years).
Tumor pathology characteristics (among those with definitive surgery)
Overall, 31.4% of the 396 tumors with definitive surgery were ≥5cm, 59.4% were 2-<5cm,
and only 9.2% were <2 cm in size at presentation. Lymphovascular invasion (LVI) was
identified in 75.3% of cases, lymph node metastases in 58.8%, and extranodal extension of
tumor in 39.1% (Table 3a).
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In post hoc analyses, we found that the most highly educated patients had the smallest
tumors (data not shown). Thus, in multivariate models evaluating the relation of ethnicity
with tumor size, we adjusted for education level as well as age and ER status; we found that
Nilotes tended to be more likely than Bantus to present with larger tumors (≥5cm vs. <2
cm), (OR: 3.86, 95% CI: 0.77, 19.30; p-trend=0.10). Continuing to compare patients from
the two major ethnic groups, we additionally found that Nilotes were more likely to present
with LVI (OR: 1.70, 95% CI: 0.68, 4.24), and were less likely to show extra nodal extension
(OR: 0.92, 95% CI: 0.45, 1.85), although none of these associations was statistically
significant (Table 3b).
Hormone receptor status
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Overall, 68.8% of the patients were ER positive, 59.4% were PR positive, and 25.6% were
HER2 positive (Table 4a). Categorized by molecular subtypes, 70.2% of patients were
Luminal A or B (ER and/or PR positive and any HER2 status), 10.6% were HER2 enriched
(ER and PR negative and HER2 positive), and 19.2% were triple negative (ER, PR and
HER2 negative).

Author Manuscript

In multivariate analyses evaluating the association between Bantu or Nilote ethnicity with
molecular tumor subtype, Nilotes tended to be more likely to be present with ER negative
tumours (36.8% versus 29.7%), although this was not statistically significant (p=0.11) and
HER2 enriched tumors as compared with Luminal A/B cases, although this difference was
also not statistically significant (OR: 1.41, 95% CI: 0.79, 2.49). Ethnicity was not associated
with the likelihood of having a triple negative tumor (OR: 1.09, 95% CI: 0.67, 1.76) (Table
4b).

DISCUSSION
This is the largest case series of histologically proven invasive breast cancers from East
Africa that has extensive and uniform risk factor information, uniform histology review, and
tumor hormone receptor status measured by immunohistochemistry in a single accredited
pathology laboratory. More than eight hundred cases were enrolled over a three-year period
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from 11 public, faith-based and private institutions that serve a full range of the geography
and population centers in Kenya.
We observed significant differences in some socio-demographic and reproductive
characteristics by ethnicity. For the largest two ethnic groups, the Bantus were significantly
more likely to be more educated, more overweight or obese, older at first pregnancy, and
younger at menopause in comparison with the Nilotes. We found no statistically significant
differences, however, in breast tumor characteristics in women from the two major ethnic
groups, although the Nilotes tended to present with somewhat larger tumors and to have a
slightly higher proportion of HER2-enriched tumors when compared with the Bantus. These
ethnic differences are likely multifactorial in nature, reflecting variations in socioeconomic,
environmental and genetic factors.
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We used tumor size, tumor grade, LVI, lymph node metastasis, and extranodal extension of
the tumor as biologic indicators of tumor aggressiveness. Whether the non-significantly
larger tumor sizes seen among the Nilotes reflects more aggressive tumor biology or a
consequence of longer delay in presentation and diagnosis is an area worthy of further
exploration. In a post hoc analysis, we observed an inverse relationship between tumor size
and level of education. Lack of or fewer years of education may limit a woman’s awareness
of breast cancer and her knowledge of breast cancer symptoms and the importance of
evaluating breast lumps, may lead to delays in presentation and diagnosis.[11] Differences in
traditional beliefs and cultural practices among ethnic groups may also explain differences in
time to presentation and tumor size at presentation.[12] Exploring these barriers to late
presentation among the various communities warrants further study.

Author Manuscript
Author Manuscript

Numerous studies of diverse populations have suggested that socio-demographic factors are
likely important for ethnic differences in breast cancer tumor size and stage at diagnosis. For
example, Awadelkarim et al reported differences in tumor characteristics between Sudanese
and Italian women; Sudanese women tended to present with larger tumors than their Italian
counterparts (48 mm vs. 22 mm), they had a higher proportion of aggressive grade 3 tumors
(68% vs. 21%), and their tumors were more likely to have nodal involvement (90% vs.
36%).[13] Additionally, a US registry-based study of the 10 largest population groups in the
US, including Hispanic, White, Black, Japanese, Filipino, Chinese, Hawaiian, Korean,
Vietnamese, and American Indian women diagnosed with breast cancer, reported that among
the Japanese and White patients, tumors were smaller in size, had a lower tumor grade (even
after adjusting for stage), and were diagnosed at an earlier stage, whereas Black and
Hispanic patients were more likely than other groups to have tumors ≥2 cm in diameter, to
have poorly differentiated tumors, and to be diagnosed with metastatic disease.[14] Apart
from possible differential exposure to carcinogens and genetic susceptibility, the known
disparities in population mammography screening levels and subsequent follow-up care may
also be contributory factors.[14] In Kenya, screening for breast cancer is opportunistic and
there is currently no national breast cancer-screening program in place.
Although we found suggestive differences in tumor hormone receptor and HER2 status
between the Nilotes and Bantus, these differences were not statistically significant. Nilote
tumors tended to be more likely to be ER negative and more likely to be HER2 positive,
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suggesting biologically more aggressive receptor phenotypes among the Nilotes. There are
multiple reports of variation in tumor hormone receptor and HER2 status in different ethnic
groups. An NCI study in the SEER registry database which examined 360,933 breast cancer
cases diagnosed between 1988-2006 showed that the Asian Indian/Pakistani women had
more ER/PR negative breast cancer than Caucasians (30.6% vs. 21.8%, p = 0.0095).[15]
Another study reported that relative to non-Hispanic Whites, women of African, Native
American, South East Asian, Mexican, South/Central American, and Puerto Rican descent
living in the United States had 1.4 to 3.1-fold elevated risks of presenting with ER and PR
negative breast cancer.[16] This report concluded that breast cancer tumor characteristics
differ by race/ethnicity in the United States and that both biological and lifestyle factors
likely contribute to these findings.[16] This hypothesis that the proportions of breast cancer
molecular subtypes differ by racial/ethnic groups is also supported by recent reports that
East African migrants to the US tend to have less ER negative breast cancer than migrants
from West Africa.[17]
The mean and median ages of breast cancer diagnosis (49 and 48 years, respectively) for all
ethnicities combined in our study population were not different from those previously
reported from Kenya.[10][18] It is noteworthy that there was a markedly earlier age at
diagnosis among the Cushites versus the two larger ethnic groups. Although this difference
in age at presentation may be suggestive of differences in tumor biology among the ethnic
groups, it could also be a chance finding due to the small number of Cushites in our patient
population.
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Over 60% of the Bantus and Nilotes in this study resided in rural areas, and about half
reported menarche at more than 15 years of age, consistent with the findings of a
Cameroonian study which reported a higher mean age at menarche for women residing in
rural areas (14.3 years) as compared to those residing in urban areas (13.8 years).[19] A
significantly greater proportion of Bantus reported age at menopause < 50 years compared to
the Nilotes and Cushites. Interestingly, a multiethnic cohort study of non-Latina Whites,
Japanese Americans, African-Americans, Native Hawaiians, and Latinas, which investigated
factors influencing the timing of natural menopause among 95,704 women, found that race/
ethnicity was a significant independent predictor of the timing of natural menopause. While
African Americans did not differ significantly from non-Latina Whites, natural menopause
occurred earlier among Latinas and later among Japanese Americans, supporting the
hypothesis that the timing of natural menopause is driven by a combination of genetic,
reproductive, and lifestyle factors.[20] Recently, genome-wide association studies (GWAS)
have identified single-nucleotide polymorphism markers that are associated with ages at
menarche[21] and menopause[22], which may aid in our understanding of the biology of
menarche and menopause.
Differences in body mass were noted between Bantus and Nilotes, with a significantly
higher proportion of Bantu patients being overweight or obese (BMI≥25 kg/m2). This may
well reflect the dietary habits of the study population. As cited by Christensen et al,[23] a
cross-sectional study in Kenya evaluating the prevalence of obesity among rural Luo
(representing the Nilotes), who mainly subsist on maize, sorghum and fish, and rural Kamba
(representing the Bantus), who subsist on maize, reported higher weights and BMIs in the
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latter. In a study of rural and urban Kenyan women, the Kamba (Bantus) had the highest
Arm Muscle Area (AMA) and the highest BMI and Arm Fat Area (AFA) as compared with
the Luo or the Maasai (both Nilotes), a finding which was marginally significant.[23]
Additionally, there were differences related to the location of residence in the prevalence of
overweight (≥BMI 25 kg/m2) women among all the rural and urban female populations
(19.5% and 60.3%, respectively).[23] In our study, there was no difference in Bantu and
Nilote cases with respect to rural or urban location of residence, which suggests that location
of residence may not contribute to ethnic differences in BMI observed in our patient
population.
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Interestingly, the mean age at first pregnancy was significantly younger for the Cushite
patients than for patients from the other ethnic groups. The Somali, Rendile, Oromo and
Borana make up the Cushitic ethnic minority, who reside in the semi-arid and arid North
Eastern region of Kenya. Traditionally within these communities, girls usually get married
before the age of 20 years. As prior studies have suggested, a full-term pregnancy before the
age of 20 years may have a transient cancer promoting effect as each pregnancy, including
the first one, may increase the risk of early-onset breast cancer [24][25][26], so early
marriages and subsequent early pregnancies could contribute to the higher proportion of
early onset pre-menopausal breast cancers seen in the Cushites vs. the other two ethnic
groups, although the cross-sectional nature of the study design along with the small number
of Cushite cases limits our ability to draw conclusions.
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The great majority of patients in all three ethnic groups reported lifetime breastfeeding of
more than 15 months, and there was no significant difference in the length of cumulative
breast feeding by ethnic group. These results are similar to those of a previous report of
mean cumulative breast feeding in the major ethnic tribes in Kenya: 12.1 months for the
Kamba (Bantus), 15.6 months for the Kikuyu (Bantus), and 17.1 months for the Luo
(Nilotes), with no significant differences among these ethnic groups.[27] Based on findings
from a large African American cohort study, it has been hypothesized that an early first birth
without subsequent breastfeeding is associated with elevated risk of ER negative breast
cancer.[28] Hence, the long lifetime duration of breastfeeding in Kenyan women of varying
ethnicities may contribute to the observed similarities in the distribution of breast cancer
molecular subtypes by ethnicity in our study population.
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Strengths of this study include the relatively large size of this African case series; the broad
national representation of the major ethnic groups in Kenya, with the majority being of
Bantu ancestry (67% versus 30% Nilotes)[29]; the use of uniform questionnaires and case
report forms; and the central pathology review and immunohistochemistry. Limitations of
the study include the fact that it was a case series, without a control population for
comparison, and the smaller representation of the Nilotes and Cushites, compared to Bantus,
which limited the interpretive power of our results. Additional studies with a larger
representation from each ethnic group and suitable population-based controls are warranted
to further our understanding of breast cancer etiology in these populations.
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CONCLUSIONS
This case series showed no significant differences in pathologic features or the molecular
subtypes, but significant differences in socio-demographic characteristics and reproductive
factors, of breast cancer cases in the three major ethnic groups in Kenya. These differences
are probably multifactorial in origin. There were insufficient cases from the Cushite ethnic
group to conclude that all three groups were clinicopathologically similar, but the available
data suggested that this was the case. This study suggests the need for studying ethnic
differences in breast cancer etiology and tumor characteristics throughout the genetically
and culturally diverse populations of sub-Saharan Africa. Such studies will clearly enhance
our overall understanding of breast cancer etiology and behavior worldwide, and may well
help us develop new strategies for prevention and early diagnosis.
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Fig 1a.

Ethinic migration patterns in Africa
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Fig 1b.

Distribution of participating study sites
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Alcohol Use

BMI classification

Occupation

Place of residence

Highest level of education

Age at diagnosis

Median age at diagnosis (IQR)

Mean age at diagnosis

50.8

49.2

23 (3.5)
129 (19.6)
209 (31.8)
296 (45.1)
4
188 (28.4)
132 (20)
181 (27.4)
160 (24.2)
0
414 (62.6)
247 (37.4)
0
224 (34)
144 (21.9)
126 (19.1)
103 (15.6)
25 (3.8)
37 (5.6)
2
152 (29.9)
213 (41.9)
143 (28.2)
153
605 (91.5)

20–29
30–39
40–49
50+
Missing
None
Primary
Secondary
Tertiary
Missing
Rural
Urban
Missing
Farmer
Employed worker
Trader
Housewife
Casual worker
Other (specify)
Missing
Normal (<25)
Overweight (25.00 - 29.99)
Obese (>=30)
Missing
No

131 (91.6)

10

44 (33.1)

40 (30.1)

49 (36.8)

0

6 (4.2)

5 (3.5)

38 (26.6)

20 (14)

45 (31.5)

29 (20.3)

0

51 (35.7)

92 (64.3)

0

41 (28.7)

25 (17.5)

24 (16.8)

53 (37.1)

0

77 (53.9)

27 (18.9)

34 (23.8)

5 (3.5)

52 (39–59)

N (%)

N (%)

48 (40–57)

Nilote
(N=143)

Bantu
(N=661)

17 (89.5)

2

7 (41.2)

5 (29.4)

5 (29.4)

0

1 (5.3)

0 (0)

11 (57.9)

5 (26.3)

2 (10.5)

0 (0)

0

18 (94.7)

1 (5.3)

0

3 (15.8)

0 (0)

2 (10.5)

14 (73.7)

0

6 (31.6)

3 (15.8)

8 (42.1)

2 (10.5)

36 (32–56)

42.7

N (%)

Cushite
(N=19)

753 (91.5)

165

194 (29.5)

258 (39.2)

206 (31.3)

2

44 (5.4)

30 (3.7)

152 (18.5)

151 (18.4)

191 (23.3)

253 (30.8)

0

316 (38.4)

507 (61.6)

0

204 (24.8)

206 (25.0)

158 (19.2)

255 (31.0)

4

379 (46.3)

239 (29.2)

171 (20.9)

30 (3.7)

48 (40–57)

49.3

N (%)

Total
(N=823)

0.95

0.11

<0.0001

<0.0001

0.0002

0.005

0.03**

P values-All*

Author Manuscript

Proportions of sociodemographic characteristics with ethnicity: All ethnicities (N=823)

0.98

0.04

0.001

0.70

0.03

0.02

0.24**

P values - Bantus and Nilotes only*

Author Manuscript
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0

55 (38.5)

88 (61.5)

0

0

6 (31.6)

13 (68.4)

0

0

351 (42.7)

472 (57.4)

0

70 (8.5)

N (%)

0.30

P values-All*

0.24

P values - Bantus and Nilotes only*

Only 3.28% (n=27) of study participants reported ever having smoked or used smokeless tobacco. Exposure to smoking is summarized here as exposed/never exposed, where exposed is defined as personal
use of tobacco as well as exposure to smoke at the workplace or home during child or adulthood.

p-values from Kruskal-Wallis test.

**

a

0

290 (43.9)

Exposed
Missing

371 (56.1)

0

Never exposed

Missing

2 (10.5)

N (%)

Total
(N=823)

p-values from chi-square test except where noted missing data were excluded from percentage calculations and statistical comparisons.

*

Author Manuscript

Exposure to smokinga

12 (8.4)

N (%)

56 (8.5)

N (%)

Author Manuscript
Yes

Cushite
(N=19)

Author Manuscript
Nilote
(N=143)

Author Manuscript

Bantu
(N=661)
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Family history of breast cancer in first degree female relative

Age at menopause†

Menopausal status

Cumulative hormonal contraception exposure

Cumulative breastfeeding

Age at first pregnancy

Parity

Age at menarche

154 (24.0)
424 (65.9)
41 (6.4)
18
28 (4.4)
29 (4.5)
585 (91.1)
19
175 (44.0)
223 (56.0)
263
348 (52.7)
312 (47.3)
1

<20 years
20 - 29 years
>= 30 years
Missing
never breastfed
< 15 months
>= 15 months
Missing
< 48 months
= 48 months
Missing
Premenopausal
Postmenopausal
Missing

609 (92.1)

24 (3.7)

Nulligravid

No

0

Missing

53

445 (67.3)

>= 3 children

98 (37.8)

188 (28.4)

1–2 children

Missing

28 (4.2)

Nulliparous

≥50 years

32

Missing

161 (62.2)

315 (50.1)

Late menarche (≥15)

< 50 years

305 (48.5)

9 (1.4)

133 (93.0)

12

37 (56.1)

29 (43.9)

1

78 (54.9)

64 (45.1)

82

29 (47.5)

32 (52.5)

6

118 (86.1)

8 (5.8)

11 (8.0)

0

13 (9.1)

71 (49.7)

50 (35.0)

9 (6.3)

0

100 (69.9)

32 (22.4)

11 (7.7)

2

62 (44.0)

79 (56.0)

0 (0)

N (%)

N (%)

Normal menarche (12 - 14)

Early menarche (<12)

Nilote
(N=143)

Bantu
(N=661)

17 (89.5)

0

4 (80.0)

1 (20.0)

0

5 (26.3)

14 (73.7)

16

2 (66.7)

1 (33.3)

0

16 (84.2)

0 (0)

3 (15.8)

0

1 (5.3)

6 (31.6)

10 (52.6)

2 (10.5)

0

14 (73.7)

2 (10.5)

3 (15.8)

1

9 (50.0)

9 (50.0)

0 (0)

N (%)

Cushite
(N=19)

Author Manuscript

Reproductive health factors by ethnicity: All ethnicities (N=823)

759 (92.2)

65

139 (42.1)

191 (57.9)

2

395 (48.1)

426 (51.9)

361

254 (55.0)

208 (45.0)

25

719 (90.1)

37 (4.6)

42 (5.3)

18

55 (6.8)

501 (62.2)

214 (26.6)

35 (4.4)

0

559 (67.9)

222 (27.0)

42 (5.1)

35

386 (49.0)

393 (49.9)

9 (1.1)

N (%)

Total
(N=823)

0.85

0.004**

0.04

0.44**

0.08**

0.0008

0.03

0.40**

P values-All*

0.72

0.007

0.10

0.21

0.15

0.0037

0.10

0.12

P values - Bantus and Nilotes
only*

Author Manuscript
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Numbers are calculated for post-menopausal women only.

p-values from Fisher exact test.

**

†

0

0

10 (7.0)
0

2 (10.5)

N (%)

p-values from chi-square test except where noted; missing data were excluded from percentage calculations and statistical comparisons.

Author Manuscript

*

52 (7.9)

Missing

Author Manuscript
Yes

N (%)

N (%)

Cushite
(N=19)

Author Manuscript
Nilote
(N=143)

0

64 (7.8)

N (%)

Total
(N=823)
P values-All*

P values - Bantus and Nilotes
only*

Author Manuscript
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0

136 (38.8)

Yes
Missing

215 (61.3)

No

0

205 (58.4)

Yes
Missing

146 (41.6)

No

0

261 (74.4)

Yes
Missing

90 (25.6)

No

13

187 (55.3)

Missing

132 (39.1)

Grade 3 (high)

4

Missing

Grade 2 (intermediate)

105 (30.3)

>5cm

19 (5.6)

208 (59.9)

2-<5 cm

Grade 1 (low)

34 (9.8)

<2 cm

0

14 (37.8)

23 (62.2)

0

22 (59.5)

15 (40.5)

0

31 (83.8)

6 (16.2)

1

18 (50.0)

16 (44.4)

2 (5.6)

0

15 (40.5)

20 (54.1)

2 (5.4)

N (%)

N (%)

0

5 (62.5)

3 (37.5)

0

6 (75.0)

2 (25.0)

0

6 (75.0)

2 (25.0)

0

2 (25.0)

5 (62.5)

1 (12.5)

0

3 (37.5)

5 (62.5)

0 (0)

N (%)

Cushite
(N=8)

0

155 (39.1)

241 (60.9)

0

233 (58.8)

163 (41.2)

0

298 (75.3)

98 (24.8)

14

207 (54.2)

153 (40.1)

22 (5.8)

4

123 (31.4)

233 (59.4)

36 (9.2)

N (%)

Total
(N=396)

0.44**

0.73**

0.45

0.34**

0.69**

P values-All*

p-values from Fisher exact test.

**

p-values from chi-square test except where noted; missing data were excluded from percentage calculations and statistical comparisons.

*

Extranodal extension

Lymph nodes with metastasis

Lymphovascular invasion

Tumor overall grade

Tumor size

Nilote
(N=37)

Bantu
(N=351)

0.91

0.90

0.21

0.82

0.37

P values - Bantus and Nilotes only*

Author Manuscript

Tumor pathology characteristics by ethnicity (limited to patients with definitive surgery, N=396)
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204

20

34

2

Bantus (N=351)

Nilotes (N=37)

1.92 (0.41, 8.99)

15

104

N

3.86 (0.77, 19.30)

ref

OR [95% CI]

≥5cm
(N=119)

0.10

p-trend

18

150

N

Grades 1 - 2
(low to
intermediate)
(N=168)

18

187

N

Tumor grade (N=373)b

0.76 (0.38, 1.52)

ref

OR [95% CI]

Grade 3 (high)
(N=205)

6

90

N

No
(N=96)

31

258

N

Yes
(N=289)

1.7 (0.68, 4.24)

Adjusted for age; 3 patients were deleted from the analysis due to missing values for age.

c

Adjusted for age; 15 patients were deleted from the analysis due to missing values for tumor grade or age.

b

ref

OR [95% CI]

Lympho-vascular Invasion
(N=385)c

Adjusted for age, education level, and estrogen receptor status; 9 patients were deleted from the analysis due to missing values for tumor size, age, or estrogen receptor status.

a

OR [95% CI]

N

N

ref

2-<5 cm
(N=224)

<2 cm
(N=36)

Tumor Size (categories) (N=379)a

15

145

N

No
(N=160)

22

203

N

Yes
(N=225)

1.01 (0.50, 2.02)

ref

OR [95% CI]

Lymph nodes w/metastasis
(N=385)c

Association between Nilote vs. Bantu ethnicity (OR [95% CI]) and tumor pathology characteristics (limited to patients with definitive surgery, N=388)

23

213

N

No
(N=236)

14

135

N

Yes
(N=149)

0.92 (0.45, 1.85)

ref

OR [95% CI]

Extranodal Extension (N=385)c
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0
466 (74.9)
156 (25.1)
0

Missing
Negative
Positive
Missing

ER- and PR- and HER2 negative (Triple Negative)

ER- and PR- and HER2 positive

(HER2+)
118 (19.0)

61 (9.8)
27 (19.9)

19 (14.0)

90 (66.2)

0

37 (27.2)

99 (72.8)

0

75 (55.2)

61 (44.9)

0

86 (64.2)

50 (36.8)

4 (22.2)

2 (11.1)

12 (66.7)

0

6 (33.3)

12 (66.7)

0

10 (55.6)

8 (44.4)

0

11 (61.1)

7 (38.9)

N (%)

Cushite
(N=18)

149 (19.2)

82 (10.6)

545 (70.2)

0

199 (25.6)

577 (74.4)

0

461 (59.4)

315 (40.6)

0

534 (68.8)

242 (31.2)

N (%)

Total
(N=776)

0.60**

0.66

0.49

0.22

P values- All*

a
47 patients were excluded from analysis due to missing data for hormone receptor status: Bantu 39, Nilote 7, and Cushite 1.

p-values from Fisher exact test.

**

0.32

0.61

0.25

0.11

P values - Bantus and Nilotes only*

p-values from chi-square test except where noted; missing data were excluded from percentage calculations and statistical comparisons.

*

376 (60.5)

Positive

443 (71.2)

0
246 (39.6)

Negative

437 (70.3)

Missing

185 (29.7)

Positive

N (%)

N (%)
Negative

ER+ and/or PR+ (Luminal type A/B)

Receptor combinations

HER2 Status

PR Status

ER Status

Nilote
(N=136)

Bantu
(N=622)

Author Manuscript

Tumor hormone receptor status by ethnicitya

Author Manuscript

Table 4a
Sayed et al.
Page 22

Breast Cancer Res Treat. Author manuscript; available in PMC 2018 February 01.

Author Manuscript
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60
19

429
90

Bantus (N=604)

Nilotes (N=136)

1.41 (0.79, 2.49)

27

115

N=142

1.09 (0.67, 1.76)

ref

OR [95% CI]

Triple Neg

Adjusted for age and age at first birth; 64 patients were excluded from the analysis due to missing data for hormone receptor status, age or age at first birth: Bantu 57, Nilote 7.

a

OR [95% CI]

N=79

N=519
ref

HER2+

Luminal A/B (comparison)

Association between Nilote vs. Bantu ethnicity (OR [95% CI]) and tumor hormone receptor statusa
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